Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis.

Yeh WZ, Widyastuti PA, Van der Walt A, Stankovich J, Havrdova E, Horakova D, Vodehnalova K, Ozakbas S, Eichau S, Duquette P, Kalincik T, Patti F, Boz C, Terzi M, Yamout BI, Lechner-Scott J, Sola P, Skibina OG, Barnett M, Onofrj M, Sá MJ, McCombe PA, Grammond P, Ampapa R, Grand'Maison F, Bergamaschi R, Spitaleri DLA, Van Pesch V, Cartechini E, Hodgkinson S, Soysal A, Saiz A, Gresle M, Uher T, Maimone D, Turkoglu R, Hupperts RM, Amato MP, Granella F, Oreja-Guevara C, Altintas A, Macdonell RA, Castillo-Trivino T, Butzkueven H, Alroughani R, Jokubaitis VG, MSBase Study Group

Open source

DOI
10.1212/wnl.0000000000012084
Published
2021 Jun 15
Container
Neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1212/wnl.0000000000012084,
  title = {Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis.},
  author = {Yeh WZ and Widyastuti PA and Van der Walt A and Stankovich J and Havrdova E and Horakova D and Vodehnalova K and Ozakbas S and Eichau S and Duquette P and Kalincik T and Patti F and Boz C and Terzi M and Yamout BI and Lechner-Scott J and Sola P and Skibina OG and Barnett M and Onofrj M and Sá MJ and McCombe PA and Grammond P and Ampapa R and Grand'Maison F and Bergamaschi R and Spitaleri DLA and Van Pesch V and Cartechini E and Hodgkinson S and Soysal A and Saiz A and Gresle M and Uher T and Maimone D and Turkoglu R and Hupperts RM and Amato MP and Granella F and Oreja-Guevara C and Altintas A and Macdonell RA and Castillo-Trivino T and Butzkueven H and Alroughani R and Jokubaitis VG and MSBase Study Group},
  year = {2021},
  journal = {Neurology},
  doi = {10.1212/wnl.0000000000012084},
  url = {https://doi.org/10.1212/wnl.0000000000012084}
}

RIS

TY  - JOUR
TI  - Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis.
AU  - Yeh WZ
AU  - Widyastuti PA
AU  - Van der Walt A
AU  - Stankovich J
AU  - Havrdova E
AU  - Horakova D
AU  - Vodehnalova K
AU  - Ozakbas S
AU  - Eichau S
AU  - Duquette P
AU  - Kalincik T
AU  - Patti F
AU  - Boz C
AU  - Terzi M
AU  - Yamout BI
AU  - Lechner-Scott J
AU  - Sola P
AU  - Skibina OG
AU  - Barnett M
AU  - Onofrj M
AU  - Sá MJ
AU  - McCombe PA
AU  - Grammond P
AU  - Ampapa R
AU  - Grand'Maison F
AU  - Bergamaschi R
AU  - Spitaleri DLA
AU  - Van Pesch V
AU  - Cartechini E
AU  - Hodgkinson S
AU  - Soysal A
AU  - Saiz A
AU  - Gresle M
AU  - Uher T
AU  - Maimone D
AU  - Turkoglu R
AU  - Hupperts RM
AU  - Amato MP
AU  - Granella F
AU  - Oreja-Guevara C
AU  - Altintas A
AU  - Macdonell RA
AU  - Castillo-Trivino T
AU  - Butzkueven H
AU  - Alroughani R
AU  - Jokubaitis VG
AU  - MSBase Study Group
PY  - 2021
JO  - Neurology
DO  - 10.1212/wnl.0000000000012084
UR  - https://doi.org/10.1212/wnl.0000000000012084
ER  -

APA

WZ, Y., PA, W., A, V. D. W., J, S., E, H., D, H., K, V., S, O., S, E., P, D., T, K., F, P., C, B., M, T., BI, Y., J, L., P, S., OG, S., M, B., M, O., MJ, S., PA, M., P, G., R, A., F, G., R, B., DLA, S., V, V. P., E, C., S, H., A, S., A, S., M, G., T, U., D, M., R, T., RM, H., MP, A., F, G., C, O., A, A., RA, M., T, C., H, B., R, A., VG, J., & Group, M. S. (2021). Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis.. Neurology. https://doi.org/10.1212/wnl.0000000000012084

Source records